[en] Alterations of tumor cell interactions with laminin, a basement membrane glycoprotein, are consistent features of the invasive and metastatic phenotype. Qualitative and quantitative changes in the expression of cell surface laminin-binding proteins have been correlated with the ability of cancer cells to cross basement membranes during the metastatic cascade. Such phenotypic modifications are usually associated with poor prognosis. In this study, the authors examined the possibility that expression of three laminin-binding proteins, the 67-kD laminin receptor (67LR), galectin-1, and galectin-3, is altered in human endometrial cancer in a fashion similar to that reported in other carcinomas, such as breast, colon, and ovarian cancer. Twenty advanced uterine adenocarcinomas were analyzed for expression of these three molecules using immunoperoxidase staining and specific antibodies. The authors found a significant increase in the expression of the 67LR and galectin-1 in cancer cells compared with normal adjacent endometrium (P = .0004 and .0022, respectively). As observed in other carcinomas, a significant down-regulation of galectin-3 expression was found in endometrial cancer cells compared with normal mucosa (P = .02). In the galectin-3 positive tumors, galectin-3 was detected in the cytoplasm and/or nucleus of cancer cells. Interestingly, tumors in which galectin-3 was detected only in the cytoplasm were characterized by deeper invasion of the myometrium than lesions where galectin-3 was found both in nucleus and cytoplasm (P = .02). This study shows an alteration of nonintegrin laminin-binding protein expression in advanced human endometrial cancer. Further studies on larger populations should determine the prognostic value of the detection of these laminin-binding proteins in endometrial carcinoma. Inverse modulation of the 67LR and galectin-3 appears to be a phenotypical feature of invasive carcinoma.
Silverberg E, Boring CC, Squires BA: Cancer statistics 1990. CA 90:40, 1990
International Federation of Gynecology and Obstetrics: Annual report on the results of treatment in gynecologic cancer: FIGO. Stockholm, Sweden, International Federation of Gynecology and Obstetrics, 1985
Castronovo V: Laminin receptors and laminin-binding proteins during tumor invasion and metastasis. Invasion Metastasis 13:1-30, 1993
Liotta LA: Tumor invasion and metastases - role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res 46:1-7, 1986
Terranova VP, Rao CN, Kalebic T, et al: Laminin receptor on human breast carcinoma cells. Proc Natl Acad Sci USA 80:444-448, 1983
Wewer UM, Liotta LA, Jaye M, et al: Altered levels of laminin receptor mRNA in various human carcinoma cells that have different abilities to bind laminin. Proc Natl Acad Sci U S A 83:7137-7141, 1986
Castronovo V, Colin C, Claysmith AP, et al: Immunodetection of the metastasis-associated laminin receptor in human breast cancer cells obtained by fine-needle aspiration biopsy. Am J Pathol 137:1373-1381, 1990
Cioce V, Castronovo V, Shmookler BM, et al: Increased expression of the laminin receptor in human colon cancer. J Natl Cancer Inst 83:29-36, 1991
Campo E, Monteagudo C, Castronovo V, et al: Detection of laminin receptor mRNA in human cancer cell lines and colorectal tissues by in situ hybridization. Am J Pathol 141:1073-1083, 1992
van den Brûle FA, Berchuck A, Bast RC, et al: Differential expression of the 67-kD Laminin Receptor and 31-kD Human Laminin Binding Protein in human ovarian carcinoma. Eur J Cancer 30A:1096-1099, 1994
Castronovo V, van den Brûle FA, Jackers P, et al: Decreased expression of galectin-3 is associated with progression of breast cancer. J Pathol 179:43-48, 1996
van den Ouweland AMW, van Duijnhoven HLP, Deichmann KA, et al: Characteristics of a multicopy gene family consisting of processed pseudogenes. Nucleic Acids Res 17:3829-3843, 1989
D'Errico A, Garbisa S, Liotta LA, et al: Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. Mod Pathol 4:239-246, 1991
Barondes SH, Cooper DN, Gitt MA, et al: Galectins: Structure and function of a large family of animal lectins. J Biol Chem 269:20807-20810, 1994
Zhou Q, Cummings RD: L-14 lectin recognition of laminin and its promotion of in vitro cell adhesion. Arch Biochem Biophys 300:6-17, 1993
van den Brûle FA, Buicu C, Baldet M, et al: Galectin-1 modulates human melanoma cell adhesion to laminin. Biochem Biophys Res Commun 209:760-767, 1995
Ochieng J, Gerold M, Raz A: Dichotomy in the lamininbinding properties of soluble and membrane-bound human galactoside-binding protein. Biochem Biophys Res Commun 186:1674-1680, 1992
van den Brûle FA, Buicu C, Sobel ME, et al: Galectin-3, a laminin-binding protein, fails to modulate adhesion of human melanoma cells to laminin. Neoplasma 42:215-219, 1995
Inohara H, Raz A: Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion. Cancer Res 55:3267-3271, 1995
Castronovo V, Campo E, van den Brûle FA, et al: Inverse modulation of steady state mRNA levels of two non-integrin laminin binding proteins in human colon carcinoma. J Natl Cancer Inst 84:1161-1169, 1992
Lotz M, Andrews CJ, Korzelius C, et al: Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci U S A 90:3466-3470, 1993
Martignone S, Pellegrini S, Villa E, et al: Characterization of two monoclonal antibodies directed against the 67 kDa high affinity laminin receptor and application for the study of breast carcinoma progression. Clin Exp Metastasis 10:379-386, 1992
Frigeri LG, Liu FT: Surface expression of functional IgE binding protein, an endogenous lectin, on mast cells and macrophages. J Immunol 148:861-867, 1992
Cooper DN, Barondes SH: Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism. J Cell Biol 110:1681-1691, 1990
Castronovo V, Buicu C, Lambert C, et al: Evaluation of a new device, the GDI Cyto-Shuttle®, for monolayer cytology preparation of the uterine cervix. FASEB J 8:A669, 1994
Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580, 1981
Graham C, Karnovsky MJ: The early stages of absorption of horseradish peroxidase in the proximal tubules of mouse kidneys: Ultrastructural cytochemistry by a new technique. J Histochem Cytochem 14:291, 1966
Castronovo V, Luyten F, van den Brûle F, et al: Identification of a 14-kDa laminin binding protein (HLBP14) in human melanoma cells that is identical to the 14-kDa galactoside binding lectin. Arch Biochem Biophys 297:132-138, 1992
Roff CF, Wang JL: Endogenous lectins from cultured cells: Isolation and characterization of carbohydrate-binding proteins from 3T3 fibroblasts. J Biol Chem 258:10657-10663, 1983
Ho MK, Springer TA: Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies. J Immunol 128:1221-1228, 1982
Sato S, Hughes RC: Control of Mac-2 surface expression on murine macrophage cell lines. Eur J Immunol 24:216-221, 1994
van den Brûle FA, Engel J, Stetler-Stevenson WG, et al: Genes involved in tumor invasion and metastasis are differentially modulated by estradiol and progestin in human breast-cancer cells. Int J Cancer 52:653-657, 1992
Lessey BA, Albelda S, Buck CA, et al: Distribution of integrin cell adhesion molecules in endometrial cancer. Am J Pathol 146:717-726, 1995
Wewer UM, Taraboletti G, Sobel ME, et al: Role of laminin receptor in tumor cell migration. Cancer Res 47:5691-5698, 1987
Agrwal N, Wang JL, Voss PG: Carbohydrate-binding protein 35: Levels of transcription and mRNA accumulation in quiescent and proliferative cells. J Biol Chem 264:17236-17242, 1989
Dagher SF, Wang JL, Patterson RJ: Identification of galectin-3 as a factor in pre-mRNA splicing. Proc Natl Acad Sci U S A 92:1213-1217, 1995
